Cargando…

Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations

BACKGROUND: Vaccine-derived polioviruses (VDPVs) have caused poliomyelitis outbreaks in communities with sub-optimal vaccination. Israeli environmental surveillance of sewage from populations with high (>95%) documented vaccine coverage of confirmed efficacy identified two separate evolutionary c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shulman, Lester M., Manor, Yossi, Sofer, Danit, Handsher, Rachel, Swartz, Tiberio, Delpeyroux, Francis, Mendelson, Ella
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762338/
https://www.ncbi.nlm.nih.gov/pubmed/17183700
http://dx.doi.org/10.1371/journal.pone.0000069
_version_ 1782131544312250368
author Shulman, Lester M.
Manor, Yossi
Sofer, Danit
Handsher, Rachel
Swartz, Tiberio
Delpeyroux, Francis
Mendelson, Ella
author_facet Shulman, Lester M.
Manor, Yossi
Sofer, Danit
Handsher, Rachel
Swartz, Tiberio
Delpeyroux, Francis
Mendelson, Ella
author_sort Shulman, Lester M.
collection PubMed
description BACKGROUND: Vaccine-derived polioviruses (VDPVs) have caused poliomyelitis outbreaks in communities with sub-optimal vaccination. Israeli environmental surveillance of sewage from populations with high (>95%) documented vaccine coverage of confirmed efficacy identified two separate evolutionary clusters of VDPVs: Group 1 (1998–2005, one system, population 1.6×10(6)) and Group 2 (2006, 2 systems, populations 0.7×10(6) and 5×10(4)). PRINCIPAL FINDINGS: Molecular analyses support evolution of nine Group 1 VDPVs along five different lineages, starting from a common ancestral type 2 vaccine-derived Sabin-2/Sabin-1 recombinant strain, and independent evolution of three Group 2 VDPVs along one lineage starting from a different recombinant strain. The primary evidence for two independent origins was based on comparison of unique recombination fingerprints, the number and distribution of identical substitutions, and evolutionary rates. Geometric mean titers of neutralizing antibodies against Group 1 VDPVs were significantly lower than against vaccine strains in all age-group cohorts tested. All individuals had neutralizing titers >1∶8 against these VDPVs except 7% of the 20–50 year cohort. Group 1 VDPVs were highly neurovirulent in a transgenic mouse model. Intermediate levels of protective immunity against Group 2 VDPVs correlated with fewer (5.0+1.0) amino acid substitutions in neutralizing antigenic sites than in Group 1 VDPV's (12.1±1.5). SIGNIFICANCE: VDPVs that revert from live oral attenuated vaccines and reacquire characteristics of wild-type polioviruses not only threaten populations with poor immune coverage, but are also a potential source for re-introduction of poliomyelitis into highly immune populations through older individuals with waning immunity. The presence of two independently evolved groups of VDPVs in Israel and the growing number of reports of environmental VDPV elsewhere make it imperative to determine the global frequency of environmental VDPV. Our study underscores the importance of the environmental surveillance and the need to reconsider the global strategies for polio eradication and the proposed cessation of vaccination.
format Text
id pubmed-1762338
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-17623382007-01-04 Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations Shulman, Lester M. Manor, Yossi Sofer, Danit Handsher, Rachel Swartz, Tiberio Delpeyroux, Francis Mendelson, Ella PLoS One Research Article BACKGROUND: Vaccine-derived polioviruses (VDPVs) have caused poliomyelitis outbreaks in communities with sub-optimal vaccination. Israeli environmental surveillance of sewage from populations with high (>95%) documented vaccine coverage of confirmed efficacy identified two separate evolutionary clusters of VDPVs: Group 1 (1998–2005, one system, population 1.6×10(6)) and Group 2 (2006, 2 systems, populations 0.7×10(6) and 5×10(4)). PRINCIPAL FINDINGS: Molecular analyses support evolution of nine Group 1 VDPVs along five different lineages, starting from a common ancestral type 2 vaccine-derived Sabin-2/Sabin-1 recombinant strain, and independent evolution of three Group 2 VDPVs along one lineage starting from a different recombinant strain. The primary evidence for two independent origins was based on comparison of unique recombination fingerprints, the number and distribution of identical substitutions, and evolutionary rates. Geometric mean titers of neutralizing antibodies against Group 1 VDPVs were significantly lower than against vaccine strains in all age-group cohorts tested. All individuals had neutralizing titers >1∶8 against these VDPVs except 7% of the 20–50 year cohort. Group 1 VDPVs were highly neurovirulent in a transgenic mouse model. Intermediate levels of protective immunity against Group 2 VDPVs correlated with fewer (5.0+1.0) amino acid substitutions in neutralizing antigenic sites than in Group 1 VDPV's (12.1±1.5). SIGNIFICANCE: VDPVs that revert from live oral attenuated vaccines and reacquire characteristics of wild-type polioviruses not only threaten populations with poor immune coverage, but are also a potential source for re-introduction of poliomyelitis into highly immune populations through older individuals with waning immunity. The presence of two independently evolved groups of VDPVs in Israel and the growing number of reports of environmental VDPV elsewhere make it imperative to determine the global frequency of environmental VDPV. Our study underscores the importance of the environmental surveillance and the need to reconsider the global strategies for polio eradication and the proposed cessation of vaccination. Public Library of Science 2006-12-20 /pmc/articles/PMC1762338/ /pubmed/17183700 http://dx.doi.org/10.1371/journal.pone.0000069 Text en Shulman et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Shulman, Lester M.
Manor, Yossi
Sofer, Danit
Handsher, Rachel
Swartz, Tiberio
Delpeyroux, Francis
Mendelson, Ella
Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title_full Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title_fullStr Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title_full_unstemmed Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title_short Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
title_sort neurovirulent vaccine-derived polioviruses in sewage from highly immune populations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762338/
https://www.ncbi.nlm.nih.gov/pubmed/17183700
http://dx.doi.org/10.1371/journal.pone.0000069
work_keys_str_mv AT shulmanlesterm neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT manoryossi neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT soferdanit neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT handsherrachel neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT swartztiberio neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT delpeyrouxfrancis neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations
AT mendelsonella neurovirulentvaccinederivedpoliovirusesinsewagefromhighlyimmunepopulations